takeaway call
despit sloppi manag remain confid outlook sequenti organ sale growth
acceler ex-sel week cc om expans ep growth
next year commentari follow-up call made clear conserv stanc taken call
reflect manag disappoint way play compani go-forward outlook
continu see organ growth achiev bar headwind like erp custom order revers
go forward tavr salesforc meaning built addit fulli train rep end
new product launch like cobalt crome high-pow stimgen dtm next-gen intelli interstim
micro ramp micra av follow approv end coupl
potenti opportun renal denerv market remain bullish compani outlook head forward
although wouldnt surpris see conserv baselin kick year enabl beat-and-rais quarter
throughout year howev given commentari wed expect manag guid someth like
organ sale growth would view organ growth highly/overli conserv start
point manag provid full-year guidanc exclud impact sell week expect
leverag extra week elimin bulk selling/quart end stock avoid kind shortfal saw today
look manag bless street number top bottom-lin exclud impact
guidanc quarter point toward organ sale growth in-lin street
earn expect come roughli back fx headwind
despit softer organ quarter time around bullish compani abil hit target respect
manag current unwil quantifi impact expect see call
lower procedur volum patient avoid hospit physician sent hubei provinc deal
crisi doctor nurs tier citi sent last week highlight headwind
earn preview last week like rais impact follow commentari today
manag aim provid addit color later quarter coupl full overview china perform
offici call may remind calcul point toward headwind use
headwind assum appli medtron china franchis could wind conserv
given spread viru sinc
dive deeper updat guidanc compani top-lin guidanc bake cvg growth
mitg growth rtg growth diabet flat lsd factor
headwind fx expect anoth benefit titan spine oper margin still
expect expand cc full-year modest benefit report basi flat exclud fx
gm see slight improv sg flat y/i come level
higher revenu base interest expens expect come quarter step
tax expect vs previous oper expens rang
expens incom non-oper item similar incom fx
reiter headwind bottom-lin quarter get us manag guid
full-year
turn quarter worth walk put take mani dynam transient
could repres tailwind highlight alert earlier morn key
driver top-lin shortfal stem erp system upgrad mitg impact final
week quarter resolv delay custom purchas cvg ahead new
product launch europe/asia pac launch us coupl lower
growth tavr mid-teen compani insuffici field coverag tackl low risk avoid
disappoint custom buy pattern rtg relat infus soft ahead
new product launch nan januari impact quarter includ slower expect recoveri
lower forecast lvad even lap start competit headwind continu replac headwind
high power abat continu competit challeng diabet
move segment level detail tavr came softer expect salesforc execut fell short
quarter like avoid dissapoint came surpris follow strong quarter
saw edward us busi grow low-double-digit ou grow mid-teen manag
highlight level rep distract large-volum account employe forc divert attent
toward open new account someth led share loss within quarter compani hire new rep
off-set new hire taken longer expect time come product curv unabl
off-set headwind address end fiscal year howev manag
highlight expect hire train increment sale rep end year
dcb franchis world-wide sale post anoth declin similar us busi
ou busi repres anoth quarter sequenti
growth domest much weaker perform intern came significantli expect
look broader peripher franchis compani saw declin high-singl digit world-wide basi
high-singl digit declin us low-singl digit growth ou
diabet franchis in-lin expect strength intern offset continu struggl
us us insulin pump mix rang cgm balanc mid-
compris consum suppli mix ou vari slightli pump cgm
consum manag specif call challeng us pump busi caus
competit headwind lower new patient start ahead launch deferr revenu patient
upgrad exist pump next-gen pump platform could modest tailwind manag
also announc plan file adult clinic data march push expect approv beyond fiscal
look toward arrhythmia manag high power high-singl digit low power high-
singl digit geograph basi high-singl digit declin high power us expect though high-
singl digit declin ou came surpris custom emea delay purchas given immin launch
cobalt chrome product famili manag also call continu tyrx headwind though suppli constraint
held back sale quarter fulli resolv low power side busi saw growth
high-singl digit us intern driven anoth strong quarter micra adopt lead high-
singl digit growth pace
declin heart failur moder low-singl digit expect lvad busi declin low-
singl digit global quarter signific improv declin busi seen last
sever quarter compani anniversari headwind competitor dt launch broader busi
includ compani crt-d crt-p devic declin low-singl digit us
intern quarter experienc continu crt-d replac headwind
busi in-lin expect high-singl digit growth repres anoth step
right direct follow mid-singl digit growth saw though sequenti deceler step
consist mid-teen growth saw world-wide last year dive deeper intern sale increas high-
singl digit rang us grew mid-singl digit tougher comp
coronari de busi continu declin global basi lsd declin driven mid-singl digit
declin us low-singl digit declin ou note mark moder sequenti improv follow
mid-singl low-doubl digit declin last sever quarter
brain solid quarter neurovascular grow mid-teen global basi driven high-singl
digit growth us high-teen growth ou ischem side busi solitair react riptid
drove growth global high-teen growth us growth ou hemorrhag side
busi saw strong growth well high-singl digit growth global driven low-singl digit us growth
low-doubl digit growth intern neurosurgeri growth also solid low-doubl growth driven high-
singl digit growth us mid-teen growth ou
spine softer expect quarter growth organ high-singl digit declin infus
off-set low-singl digit growth core spine latter affect custom drawdown inventori
spine driven robot pull-through result increas spine implant spine grew low-singl digit
us ou grew organ includ sale enabl technolog brain therapi
analyst certif research analyst denot ac cover report certifi multipl research
analyst primarili respons report research analyst denot ac cover within document
individu certifi respect secur issuer research analyst cover research view
express report accur reflect research analyst person view subject secur issuer
part research analyst compens directli indirectli relat specif recommend
view express research analyst report korea-bas research analyst list front cover applic
also certifi per kofia requir analysi made good faith view reflect opinion
without undu influenc intervent
author name within report research analyst unless otherwis specifi europ sector specialist may shown
report contact author report part research depart
 morgan seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report singl
factor make invest decis
market maker/ liquid provid morgan market maker and/or liquid provid financi instrument of/rel
plc
client morgan current within past month follow entiti client medtron plc
client/invest bank morgan current within past month follow entiti invest
client/non-invest bank securities-rel morgan current within past month follow
entiti client servic provid non-investment-bank securities-rel medtron plc
client/non-securities-rel morgan current within past month follow entiti client
servic provid non-securities-rel medtron plc
invest bank past month morgan receiv past month compens invest bank servic
plc
invest bank next month morgan expect receiv intend seek compens invest bank
servic next three month plc
non-invest bank compens morgan receiv compens past month product servic
invest bank plc
debt posit morgan may hold posit debt secur plc
 morgan secur llc and/or affili act financi advisor mazor robot connect merger
plc announc septemb transact subject sharehold regulatori approv research
report inform contain herein intend provid vote advic serv endors propos transact
result procur withhold revoc proxi action secur holder
company-specif disclosur import disclosur includ price chart credit opinion histori tabl avail
compendium report morgancov compani visit http //www jpmm com/research/disclosur call
e-mail request morgan strategi technic quantit
research team may screen compani cover morgan import disclosur compani pleas call
email
bloomberg morgan price data adjust stock split dividend
initi coverag feb share price market close previou busi day
chart show morgan continu coverag stock current analyst may may cover entir
 morgan rate design ow overweight neutral uw underweight nr rate
explan equiti research rate design analyst coverag univers
 morgan use follow rate system overweight next six twelv month expect stock outperform
averag total return stock analyst analyst team coverag univers neutral next six twelv
month expect stock perform line averag total return stock analyst analyst team
coverag univers underweight next six twelv month expect stock under-perform averag total return
stock analyst analyst team coverag univers rate nr morgan remov rate
applic price target stock either lack suffici fundament basi legal regulatori polici
reason previou rate applic price target longer reli upon nr design
recommend rate asia ex-australia ex-india small- mid-cap equiti research stock expect
total return compar expect total return benchmark countri market index analyst coverag univers
appear import disclosur section report certifi analyst coverag univers found
